Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA)
- 30 September 1992
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 20 (3), 513-519
- https://doi.org/10.1016/0735-1097(92)90001-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1990
- Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS studyThe Lancet, 1990
- Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator.Circulation, 1989
- A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction.Circulation, 1989
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activityBlood, 1988
- Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysisJournal of the American College of Cardiology, 1987
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- D-PHE-PRO-ARGCH2Cl-A selective affinity label for thrombinThrombosis Research, 1979
- A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test)Clinica Chimica Acta; International Journal of Clinical Chemistry, 1963